|18 August, 2019

Industrial Development & Workers Bank seeks to acquire Egy Lease’s stake in MUP

Egy Lease aims to sell its entire stake of 10.4% in Medical Union Pharmaceuticals

Traders work at the Egyptian stock exchange in Cairo, Egypt, December 3, 2015.

Traders work at the Egyptian stock exchange in Cairo, Egypt, December 3, 2015.

REUTERS/Mohamed Abd El Ghany

Cairo –   Industrial Development and Workers Bank of Egypt is currently in negotiations to acquire Egy Lease’s entire stake in Medical Union Pharmaceuticals (MUP), chairperson of Egy Lease, Iman Ismail, said.

Egy Lease, totally owned by the Industrial Development & Workers Bank of Egypt, seeks to sell its entire stake of 10.4% in MUP in a deal expected to exceed EGP 200 million in value, Ismail told Mubasher on Sunday.

The company submitted a request to the General Authority for Investment and Free Zones (GAFI) to change its status to a joint stock company from a limited liability company to begin stake sale procedures.

On 16 July, the Egyptian International Pharmaceutical Industries (EIPICO) rejected an offer to acquire Egy Lease’s entire stake of 10.4% in MUP and initiated talks with Egy Lease to purchase a 9.77% stake instead, Ismail previously revealed.

During the first half of 2019, EIPICO logged a profit of EGP 398.3 million, compared to EGP 388.3 million in H1-18, including minority shareholders’ rights, according to the company’s consolidated financial results.

Sales grew to EGP 1.7 billion in the six-month period ended 30 June, compared to EGP 1.4 billion in the year-ago period.

As for standalone business, EIPICO’s profit registered EGP 371.2 million in H1-19, compared to EGP 368.5 million in H1-18, including minority shareholders’ rights.

Source: Mubasher Exclusive

All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Equities